October 8, 2018—UC San Diego Altman Clinical and Translational Research Institute (ACTRI) and UC San Diego Institute of Engineering in Medicine (IEM) are pleased to announce a new seminar series that highlights the research projects from the Galvanizing Engineering in Medicine (GEM) grant program. GEM, a collaboration between ACTRI and IEM, was established in 2013 to bring engineers and clinicians together to develop innovative technologies to solve challenging problems in medical care. GEM has funded 19 projects.
“This year, we are introducing a seminar series “Healthcare Horizons – Galvanizing Engineering in Medicine” that will showcase the GEM projects and provide a forum for establishing more collaborations between clinicians and engineers,” said Deborah Spector, PhD, Co-director of the ACTRI Translational Science Alliance and one of the leaders of the GEM initiative.
The seminars will be held at 5 p.m. on the first and third Monday of the month, beginning November 5th, in the large seminar room in the Center for Neural Circuits and Behavior building at UC San Diego. The format will consist of one or two prior GEM awardees giving a 15- to 20-minute presentation followed by questions and time for networking. Clinical attendees will also be asked to list an important healthcare challenge in their field that is amenable to an engineering solution and engineering attendees to provide a short description (one to two sentences) of their area of expertise. The responses will be collated and sent to all individuals who have attended the seminar and provided their e-mail address. With permission from the attendee, these will also be posted on the ACTRI website.
The GEM competition this year will consist of only one phase with an application submitted by the Clinician-Engineer team. The due date will be at the end of March, 2019. “We hope that the seminar series will “galvanize” the formation of new teams to develop innovative engineering solutions for challenging problems in healthcare,” Spector said.
View the Healthcare Horizons schedule
About UC San Diego Altman Clinical and Translational Research Institute:
UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is part of a national Clinical and Translational Science Award consortium, led by the National Institutes of Health National Center for Advancing Translational Science. Established in 2010, ACTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. ACTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,500 members.